3 Small-Cap Biotech Stocks That Soared Last Week

What do platelets, wounds, and blindness have in common? Treatments for all three helped these stocks climb 26% last week.

Do any of these small-cap biotechs have what it takes to keep climbing? Here's what you need to know.